You guys would fail Scientific Method 101, which my kids are studying at elementary school now.
Merely talking about something does not suddenly make it real. In order to prove that it is worth combining RECAF with other tests you need to spend time, effort and money doing the appropriate tests and documenting the results. That is what has happened with the latest announcement re CA-125. The latest announcement is valid news for this reason -- it reports something new (data) that carries scientific weight.
Merely discussing combination of RECAF with PSA four years ago cuts no weight. You would need to do the tests and report the data, which never happened.
Predictably, the next observation from GS is going to be that Abbott decided not to do RECAF/PSA tests because they realize RECAF is worthless. In fact, large companies like Abbott don't innovate. They sit back and wait for small companies to do the basic science and take an idea far enough towards commercialization that they (i.e., the large companies) can simply step in and license it. IMO that is what the large companies are doing. They are waiting for biocurex to provide enough hard data to satisfy them it will work.
QB
